» Articles » PMID: 37554270

Engineering Strategies and Optimized Delivery of Exosomes for Theranostic Application in Nerve Tissue

Overview
Journal Theranostics
Date 2023 Aug 9
PMID 37554270
Authors
Affiliations
Soon will be listed here.
Abstract

Severe injuries or diseases affecting the peripheral and central nervous systems can result in impaired organ function and permanent paralysis. Conventional interventions, such as drug administration and cell-based therapy, exhibit limited effectiveness due to their inability to preserve post-implantation cell survival and impede the deterioration of adjacent tissues. Exosomes have recently emerged as powerful tools for tissue repair owing to their proteins and nucleic acids, as well as their unique phospholipid properties, which facilitate targeted delivery to recipient cells. Engineering exosomes, obtained by manipulating the parental cells or directly functionalizing exosomes, play critical roles in enhancing regenerative repair, reducing inflammation, and maintaining physiological homeostasis. Furthermore, exosomes have been shown to restore neurological function when used in combination with biomaterials. This paper primarily focuses on the engineering strategies and delivery routes of exosomes related to neural research and emphasizes the theranostic application of optimized exosomes in peripheral nerve, traumatic spinal cord, and brain injuries. Finally, the prospects of exosomes development and their combination with other approaches will be discussed to enhance our knowledge on their theranostic effectiveness in neurological diseases.

Citing Articles

Innovating intervertebral disc degeneration therapy: Harnessing the power of extracellular vesicles.

Chen S, Dou Y, Zhang Y, Sun X, Liu X, Yang Q J Orthop Translat. 2025; 50:44-55.

PMID: 39868351 PMC: 11761297. DOI: 10.1016/j.jot.2024.09.014.


The Opportunities and Challenges of Mesenchymal Stem Cells-Derived Exosomes in Theranostics and Regenerative Medicine.

Yadav S, Maity P, Kapat K Cells. 2024; 13(23).

PMID: 39682706 PMC: 11640604. DOI: 10.3390/cells13231956.


Exosomes to exosome-functionalized scaffolds: a novel approach to stimulate bone regeneration.

Deng L, Liu Y, Wu Q, Lai S, Yang Q, Mu Y Stem Cell Res Ther. 2024; 15(1):407.

PMID: 39521993 PMC: 11550564. DOI: 10.1186/s13287-024-04024-4.


An injectable decellularized extracellular matrix hydrogel with cortical neuron-derived exosomes enhances tissue repair following traumatic spinal cord injury.

Wang G, Li Q, Liu S, Li M, Liu B, Zhao T Mater Today Bio. 2024; 28:101250.

PMID: 39318371 PMC: 11421349. DOI: 10.1016/j.mtbio.2024.101250.


Therapeutic Potential and Challenges of Mesenchymal Stem Cell-Derived Exosomes for Peripheral Nerve Regeneration: A Systematic Review.

Dogny C, Andre-Levigne D, Kalbermatten D, Madduri S Int J Mol Sci. 2024; 25(12).

PMID: 38928194 PMC: 11203969. DOI: 10.3390/ijms25126489.


References
1.
Lopez-Leal R, Court F . Schwann Cell Exosomes Mediate Neuron-Glia Communication and Enhance Axonal Regeneration. Cell Mol Neurobiol. 2016; 36(3):429-36. PMC: 11482438. DOI: 10.1007/s10571-015-0314-3. View

2.
Wang C, Wang M, Xia K, Wang J, Cheng F, Shi K . A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury. Bioact Mater. 2021; 6(8):2523-2534. PMC: 7873581. DOI: 10.1016/j.bioactmat.2021.01.029. View

3.
Wang G, Lu P, Qiao P, Zhang P, Cai X, Tang L . Blood vessel remodeling in late stage of vascular network reconstruction is essential for peripheral nerve regeneration. Bioeng Transl Med. 2022; 7(3):e10361. PMC: 9472024. DOI: 10.1002/btm2.10361. View

4.
Yang Z, Yang Y, Xu Y, Jiang W, Shao Y, Xing J . Biomimetic nerve guidance conduit containing engineered exosomes of adipose-derived stem cells promotes peripheral nerve regeneration. Stem Cell Res Ther. 2021; 12(1):442. PMC: 8343914. DOI: 10.1186/s13287-021-02528-x. View

5.
Ren Z, Zhou J, Xiong Z, Zhu F, Guo X . Effect of exosomes derived from MiR-133b-modified ADSCs on the recovery of neurological function after SCI. Eur Rev Med Pharmacol Sci. 2019; 23(1):52-60. DOI: 10.26355/eurrev_201901_16747. View